|
Apr 15
|
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
|
|
Apr 15
|
Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada
|
|
Apr 4
|
Competition watchdog says HRT drug deal could raise prices
|
|
Apr 4
|
UPDATE 1-UK watchdog says Theramex-Viatris deal raises competition concerns
|
|
Apr 1
|
UPDATE 1-Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
|
|
Apr 1
|
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
|
|
Apr 1
|
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
|
|
Apr 1
|
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
|
|
Mar 29
|
Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?
|
|
Mar 27
|
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
|
|
Mar 14
|
Is Viatris a Great Dividend Stock or Just a Value Trap?
|
|
Mar 11
|
2 Dirt Cheap Dividend Stocks to Buy and Hold
|
|
Mar 11
|
UPDATE 1-US FDA declines to approve Viatris's injection for multiple sclerosis
|
|
Mar 8
|
Viatris Inc's Dividend Analysis
|
|
Mar 6
|
Insider Sell: President of Greater China Xiangyang Ni Sells 21,532 Shares of Viatris Inc (VTRS)
|
|
Mar 5
|
Viatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript
|
|
Mar 5
|
13 Best Pharma Dividend Stocks To Buy in 2024
|
|
Mar 4
|
Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise
|
|
Jan 25
|
Here’s Why Greenlight Decided to Repurchase Viatris (VTRS)
|
|
Jan 22
|
12 S&P 500 Stocks On the Move
|